AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer

NCT01287130 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Colonic Neoplasms
Cancer of the Colon
Colon Cancer
Colon Neoplasms
Colonic Cancer

Interventions

DRUG: Cetuximab
DRUG: AZD6244

Sponsor

National Cancer Institute (NCI)